CAMBRIDGE TRUST CO - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAMBRIDGE TRUST CO ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$718,000
+5.6%
30,2000.0%0.03%
+29.2%
Q1 2022$680,000
+13.7%
30,2000.0%0.02%
+26.3%
Q4 2021$598,000
-49.7%
30,200
-50.0%
0.02%
-20.8%
Q3 2021$1,188,000
+78.9%
60,400
+100.0%
0.02%
-4.0%
Q2 2021$664,000
-7.5%
30,2000.0%0.02%
-13.8%
Q1 2021$718,000
-9.1%
30,2000.0%0.03%
-21.6%
Q4 2020$790,000
+41.1%
30,200
-6.2%
0.04%
+27.6%
Q3 2020$560,000
+10.9%
32,2000.0%0.03%
+7.4%
Q2 2020$505,000
+31.9%
32,2000.0%0.03%
+3.8%
Q1 2020$383,000
-1.8%
32,2000.0%0.03%
+23.8%
Q4 2019$390,000
-22.9%
32,200
-10.1%
0.02%
-27.6%
Q3 2019$506,000
+26.8%
35,8000.0%0.03%
+26.1%
Q2 2019$399,000
-5.0%
35,8000.0%0.02%
-8.0%
Q1 2019$420,000
-12.1%
35,8000.0%0.02%
-24.2%
Q4 2018$478,000
-4.8%
35,8000.0%0.03%
+13.8%
Q3 2018$502,000
-10.8%
35,8000.0%0.03%
-17.1%
Q2 2018$563,000
-4.4%
35,8000.0%0.04%
-7.9%
Q1 2018$589,000
-9.0%
35,8000.0%0.04%
-7.3%
Q4 2017$647,000
-16.2%
35,800
-10.5%
0.04%
-21.2%
Q3 2017$772,000
+63.6%
40,0000.0%0.05%
+57.6%
Q2 2017$472,000
+7.8%
40,0000.0%0.03%
+13.8%
Q1 2017$438,000
+51.0%
40,0000.0%0.03%
+45.0%
Q4 2016$290,000
+11.5%
40,0000.0%0.02%
+5.3%
Q3 2016$260,000
+19.3%
40,0000.0%0.02%
+11.8%
Q2 2016$218,000
+16.6%
40,0000.0%0.02%
+13.3%
Q1 2016$187,000
-6.0%
40,0000.0%0.02%
-6.2%
Q4 2015$199,000
+32.7%
40,0000.0%0.02%
+23.1%
Q3 2015$150,000
-37.5%
40,0000.0%0.01%
-35.0%
Q2 2015$240,000
-14.3%
40,000
-20.0%
0.02%
-16.7%
Q1 2015$280,000
+86.7%
50,0000.0%0.02%
+84.6%
Q4 2014$150,000
+11.9%
50,0000.0%0.01%
+8.3%
Q3 2014$134,000
-4.3%
50,0000.0%0.01%0.0%
Q2 2014$140,000
-35.8%
50,0000.0%0.01%
-40.0%
Q1 2014$218,000
+35.4%
50,0000.0%0.02%
+33.3%
Q4 2013$161,000
+101.2%
50,0000.0%0.02%
+87.5%
Q3 2013$80,000
-8.0%
50,0000.0%0.01%
-11.1%
Q2 2013$87,00050,0000.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,370,017$181,2959.31%
Novo Holdings A/S 3,377,768$73,162,4554.83%
Parallel Advisors, LLC 3,724,573$80,674,2512.72%
TANAKA CAPITAL MANAGEMENT INC 35,539$7702.24%
Shay Capital LLC 350,000$7,581,0001.49%
Shay Capital LLC 350,000$7,581,0001.49%
S&T BANK/PA 350,924$7,6011.37%
Birchview Capital, LP 50,000$1,0830.85%
Clearview Wealth Advisors LLC 34,275$742,3970.75%
Granite Investment Partners, LLC 795,076$17,221,3460.72%
View complete list of CORCEPT THERAPEUTICS INC shareholders